Abiraterone acetate (Zytiga) is combined with prednisone to treat metastatic castration-resistant prostate cancer (mCRPC). Newly diagnosed high-risk metastatic endocrine therapy-sensitive prostate cancer (mCRPC), including not receiving endocrine therapy or receiving endocrine therapy for a maximum of 3 months. The recommended dose of abiraterone acetate (Zytiga) is 1000 mg (4×250 mg tablets) orally once a day, combined with prednisone 5 mg orally twice a day. This product must be taken on an empty stomach. Taking it with food will increase the systemic exposure of this product. Do not eat at least 2 hours before taking this medicine, and at least 1 hour after taking this product (see [Pharmacokinetics]). This product should be swallowed whole with water. Do not break or chew. Stop taking Abiraterone acetate (ZYTIGA) and seek medical attention immediately if you notice signs of low blood potassium levels, such as muscle weakness, muscle cramps and heart palpitations. The most common adverse reactions to Abiraterone acetate (ZYTIGA) are: swelling in the legs and feet, low blood potassium, urinary tract infection, high blood pressure and bone fractures. Other adverse reactions seen during treatment with ZYTIGA they are: high blood fat levels, increased results of liver function tests, chest pain, heart beat disorders, heart failure, rapid heart beat and problems with the adrenal glands. If these or other adverse events occur, talk to your doctor immediately. To order online Abiraterone acetate from us please visit our official website www.medixocentre.com & make your enquiry or you can send message on our WhatsApp- +91-9999344593.